Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 453,346 |
|
|||||
| News | - | ||||||
| Day High | 195.58 | Low High |
|||||
| Day Low | 189.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.38 | -0.71% | 193.00 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 192.49 | 189.00 | 195.58 | 193.33 | 194.38 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,623 | 453,346 | US$ 192.96 | US$ 87,478,642 | - | 119.7604 - 322.67 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:39:17 | formt | 100 | US$ 193.00 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.85B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 221.01 | 225.66 | 189.00 | 207.76 | 608,088 | -28.01 | -12.67% |
| 1 Month | 267.28 | 267.00 | 189.00 | 228.29 | 405,638 | -74.28 | -27.79% |
| 3 Months | 219.15 | 298.00 | 168.2462 | 234.42 | 612,564 | -26.15 | -11.93% |
| 6 Months | 123.08 | 298.00 | 119.7604 | 219.78 | 481,506 | 69.92 | 56.81% |
| 1 Year | 294.31 | 322.67 | 119.7604 | 212.84 | 429,318 | -101.31 | -34.42% |
| 3 Years | 130.28 | 322.67 | 52.33 | 178.38 | 316,669 | 62.72 | 48.14% |
| 5 Years | 106.76 | 322.67 | 52.33 | 158.09 | 256,576 | 86.24 | 80.78% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
